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Abstract
Background: Patient safety is a top priority for registered nurses (RNs) while caring for
individuals in the healthcare setting. Of the various responsibilities of an inpatient RN,
administering injectable medications pose significant risks to patients if done incorrectly. Given
these known risks, the RNs of an inpatient medical-surgical microsystem were studied during the
process of preparing these medications.
Local Problem: Through observations (N = 20), it was noticed that 13 (65%) of the preparations
were done at a location referred to as the nurse server counter. This is problematic since this
location does not provide the RN with access to the electronic medication administration record
(eMAR), meaning that these preparations were done without verifying the Seven Rights of
Medication Administration. These findings generated this quality improvement (QI) project and
the specific aim to decrease the percentage of RNs that prepare injectable medications at this
location from 65% to 50% by July 29, 2022.
Methods: A pre-implementation survey, assessing the RNs’ knowledge of safe medication
practices and how often they access the eMAR during medication preparation was distributed.
This survey facilitated in outlining the intervention, including the plan to gather an additional 20
observations. The Plan-Do-Study-Act model of improvement was selected as the framework for
this project. Descriptive statistical analysis was used to analyze the results.
Intervention: The intervention began with an informed consent process, which allowed RNs to
agree to participate. Educational meetings were held with the participants which reviewed topics
relating to the importance of safe medication practices. Then, visual reminders were put on
display throughout the microsystem which were meant to redirect RNs to prepare medications
with the eMAR open. The RNs were then observed as they prepared injectable medications.
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Finally, the participants were asked to complete a survey which assessed the effectiveness of the
intervention.
Results: Six RNs provided consent to participate in the intervention. The project was terminated
after collecting only 10 observations given this cycle’s deadline of July 29, 2022. Of the 10
observations of preparing injectable medications (N = 10), one (10%) was done at the nurse
server counter. Additionally, five of the six RNs completed the post-implementation survey. The
responses indicate that the educational meetings were helpful in enhancing the RNs’ knowledge
of safely preparing medications for their patients, but also that observer bias was present during
the observations.
Conclusions: Although it appears that the specific aim was met, only 10 observations were
collected. Additionally, the presence of observer bias interfered with the data collection process,
indicating that the results do not reflect the actual practices of the RNs. However, the responses
from the survey indicated that the intervention efforts did enhance the RNs’ knowledge of safe
medication practices and identified the need to improve access to the eMAR throughout the
microsystem.
Keywords: patient safety, electronic medication administration record, injectable
medications, Seven Rights of Medication Administration, quality improvement
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Introduction
Problem Description
Registered nurses (RNs) working in the inpatient setting are responsible for various tasks
to help advance patient care. Of these tasks, the preparation and administration of medications
tend to be emphasized given the potential to cause patient harm if these processes are done
incorrectly. While all medications can cause adverse effects, injectable medications, like those
given via intravenous push (IVP) and subcutaneously, are known to carry greater risks since they
are administered directly into the circulation or body tissues. Also, errors are more likely to
result from injectable medications given the complex preparation process. Prior to
administration, nurses must manually withdraw the medicine by first puncturing the vial with a
needle that is attached to a syringe. Once the tip of the needle is in contact with the medication in
the vial, the nurse then pulls back the plunger of the syringe to remove the desired amount. This
process, known as the traditional method of preparation, requires the preparer to have adequate
dexterity and psychomotor skills to be able to execute this correctly. As a result, the preparation
of these medications has been identified as a critical part of the medication administration (MA)
process and must be regarded as such by those responsible for providing medications to patients.
Since nurses are responsible for MA, they are expected to verify medication orders
throughout the processes of preparing and administering medicine. The Five Rights of
Medication Administration serve as reminders for RNs to ensure that the right patient receives
the right dose of the right drug via the right route at the right time (Hanson & Haddad, 2021).
Nurses are expected to be familiar with these rights upon entry into practice and are reminded of
their importance throughout their professional career. Some healthcare settings, including the
microsystem that was studied throughout this project, adhere to an additional two rights
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(documentation and reason). Collectively, these are known as the Seven Rights of Medication
Administration. To promote the adherence to the rights of MA, several healthcare organizations
have incorporated certain technologies, such as barcoded medications, scanners, and an
electronic medication administration record (eMAR), to support RNs during MA. When used
concurrently, these advancements help to ensure RNs provide medications to their patients as
directed which can reduce the risks of adverse effects and medication administration errors
(MAEs).
Barcoded medications, scanners, and the eMAR are key components that make up the
barcode medication administration (BCMA) system. The purpose of BCMA is to reduce the risks
related to human error during MA. Though this works in theory, it is known to be less effective
in practice due to barriers like inadequate access to technology at locations where medications
are prepared and nurses’ beliefs that they are familiar enough with the order details of commonly
prescribed medications. Unfortunately, BCMA is not present in all healthcare facilities because
of its associated costs and technology requirements. However, the addition of BCMA is
increasing due to its known impact on intercepting MAEs before they reach the patient. For the
settings where BCMA is present, it is considered best practice to utilize all components of the
system, including the order details within the eMAR, during active medication preparation and
administration (Smeulers et al., 2015). Nurses are expected to adopt the use of BCMA into their
practice to verify the rights of MA and protect their patients from preventable harm.
To further investigate the barriers to accepting the BCMA system and performing the
Seven Rights of Medication Administration, the RNs of an inpatient medical-surgical
microsystem were observed during the preparation and administration of injectable medications.
Prior to creating an actual data collection plan, general observations were made to identify trends
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in the RNs’ MA practices. The initial observations suggested that the nurses tend to prepare most
injectable medications at the counter at the nurse server station. It was believed that this was the
preferred location because this is where the necessary supplies for preparing these medications,
like needles, syringes, and alcohol wipes, were stored. However, this was identified as a problem
because there is no access to the eMAR at this location, indicating that these medications were
being prepared without considering the rights of MA, including the right dose. Because of this
realization, the decision was made to conduct further observations to better describe this
problem.
Over the course of two months, the RNs were observed during the preparation of
injectable medications a total of 20 times. Common medications that were prepared during these
observations included subcutaneous insulin, subcutaneous heparin, and IVP pantoprazole. These
observations were gathered during the 7:00am-7:00pm shift throughout the Monday-Friday fiveday week. Of the 20 observations, 13 (65%) preparations were completed at the nurse server
counter. In other words, 65% of the observed preparations were completed without accessing the
eMAR and verifying the dosage during this process. The results from these observations suggest
the need for changing this common practice and initiated this quality improvement (QI) project.
Given the consequences that this problem can have on patient safety, thoughtful
consideration was given while identifying an intervention to improve this process. Because the
microsystem’s RNs are the individuals responsible for MA, a pre-implementation survey was
distributed to the RNs which assessed their perceptions and beliefs regarding safe preparation of
injectable medications. 16 RNs were identified as being directly involved with patient care,
which includes the processes of MA. Nine (56.3%) of the RNs successfully completed the
survey. At the start of the survey, the nurses were asked if they believe that they safely prepare
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and administer injectable medications to their patients. Seven (77.8%) of the RNs responded as
doing this Always and two (22.2%) responded as Often. Additionally, when asked to report the
frequency at which the RNs refer to the eMAR while actively preparing injectable medications,
the responses were as follows: Always (n = 1 [11.1%]), Often (n = 4 [44.4%]), and Sometimes (n
= 4 [44.4%]). Though these responses support the idea that the observed practices are a problem,
more information was needed to help inform a practical intervention. When asked where the RNs
prefer to prepare these medications, 100% responded that their preferred location is the counter
at the nurse servers. The nurses identifying this location as their preferred spot to prepare
injectable medications provided insight that the nurse server station is the ideal location to
include in the intervention. This is because it has the most potential to redirect the RNs to access
the eMAR during preparation. The survey also asked the nurses if they believed placing a
computer at this counter would encourage them to view the eMAR during preparation; the results
show that eight (88.9%) of the respondents found this to be a good idea. This is important to note
because it suggests that the potential cause of this problem is due to a lack of access to
technology at the staff’s preferred location for preparing medications. Finally, the RNs were
asked if visual reminders to access the eMAR during preparation would encourage them to
incorporate this process into their practice. The responses were as follows: Yes (n = 3 [33.3%]),
Maybe (n = 6 [66.7]), and No (0%). The results from this question indicate that reminders and
continuous education on the importance of referencing the eMAR while preparing injectable
medications may help to improve the current practice.
Available Knowledge
Despite the importance of accessing the eMAR during medication preparation, as
suggested by best practice guidelines, recent evidence shows that RNs are reluctant to adhere to
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these guidelines for several different reasons. A systematic review analyzing the knowledge and
behaviors of RNs as they prepare and administer injectable medications to patients in the
inpatient setting was conducted by Luokkamäki et al. and published in 2020. According to this
review, RNs providing their patients with the wrong dose of a drug is a common cause of MAEs
and is typically due to the failure to double-check the prescribed information (Luokkamäki et al.,
2020). During the data collection process, the researchers conducted various searches across
databases, like Cochrane and PubMed, and ultimately included a total of 22 studies within the
2007-2017 timeframe. The analysis of these studies defined several key processes in the overall
medication administration process, with preparation as one of them. After reviewing each of the
studies, the researchers conclude that several of the identified MAEs were caused by insufficient
checking practices during the preparation phase (Luokkamäki et al., 2020). Highlighting this
finding supports the need for RNs to adequately use their resources, like the eMAR, when
handling medications.
An observational study published in 2018 by Hertig et al. attempted to identify the known
risks associated with preparing injectable medications via traditional practice. While providing
context to the article, the researchers state, “an estimated 44% of nurses administer injectable
medications more than 5 times per shift” (Hertig et al., 2018, p. 60). Given how common these
medications are used in practice, they are associated with error rates as high as 97.7%, with 48%
of these errors taking place during the preparation or administration phases (Hertig et al., 2018).
The investigators collected data through observations at three different healthcare sites in various
locations throughout the United States during 2015 and 2016. The RNs that participated in this
study were either assigned to the group that would prepare and administer ready-to-administer
products or to the group that was responsible for preparing and administering medications via
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traditional practice. The observation period began as soon as the RN removed the medication
from the automated dispensing cabinet and concluded once the medication had been
administered to the patient. To provide the observers with objective criteria to define an error,
the researchers created an eight-step process for both observational groups that served as
guidelines for the phases of administration. An error was defined as “a deviation of the observed
medication preparation and administration from the previously defined steps or any deviation
from the original medication order” (Hertig et al., 2018, p. 62). At the conclusion of the data
collection process, a total of 337 hours of direct observations throughout all sites were
completed. Of the 329 observations, 260 errors were reported, including 235 due to errors with
traditional practice preparation and administration techniques (Hertig et al., 2018). An example
of an observed error during this method of medication administration was incorrect labeling of
syringes once the medication was removed from the vial. Given the added steps during
traditional practice preparation, RNs have a greater risk of making an error when working with
these medications which puts the patient at a greater risk for harm. This risk potential directly
applies to this microsystem, as many of the injectable medications ordered for patient use require
preparation via a vial and syringe.
Though the implementation of BCMA technology is known to reduce the occurrence of
MEs, research supports the finding that nurses are still reluctant to completely accept BCMA as
part of their nursing practice. An observational study was designed to investigate this further by
observing 44 RNs while they prepared and administered a total of 884 medications to 213
patients (Mulac et al., 2021). Of the 213 patients included in the study, a total of 30 (14.1%)
patients’ medications were prepared incorrectly by RNs (Mulac et al., 2021). However, for 11
(36.7%) of the 30 patients, the use of the eMAR informed the RN of the error and prevented
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them from administering the medication to the patient (Mulac et al., 2021). These results support
the need for RNs to incorporate the components of BCMA into their MA practices to promote
patient safety. The article concludes by suggesting that RNs should be observed frequently for
their adherence to BCMA and double-checking practices, much like the observations that were
made within the microsystem during the pre-implementation phase of this QI project. The
findings from these assessments can identify specific barriers to implementation which is useful
when planning interventions to help combat these challenges.
To better support RNs during the preparation and administration of injectable
medications, Smeulers et al. (2015) conducted a systematic review in which they identified
specific quality indicators to enhance these processes. As published within the article, “quality
indicators are explicitly defined and measurable items referring to the structure, processes, or
outcome of care” (Smeulers et al., 2015, p. 2). After reviewing the articles, a total of 21 quality
indicators were identified (five structure indicators, including the implementation of reporting
systems; eleven process indicators, like documenting adverse events and verifying high alert
medications; and five outcome indicators, such as patient reactions to medication errors). The
researchers then classified each of these indicators based on their relevance to the rights of MA.
Once this was completed, it was noticed that most of these indicators directly relate to the RNs
responsibility to provide patients with the right dose of their medication (Smeulers et al., 2015).
To ensure that the correct dose is given during MA, the researchers conclude that certain quality
indicators, such as implementing electronic verifications, specific medication-based protocols,
and providing staff with visual reminders, were found to be most effective (Smeulers et al.,
2015). The information presented throughout this systematic review was instrumental to the
process of identifying an appropriate intervention for this QI project.
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The articles included within this review of the available knowledge helped to better
understand the pre-implementation state of the identified microsystem. Moreover, they have
facilitated in recognizing the most appropriate, evidence-based intervention to guide change.
Given the risks for harm associated with injectable medications, RNs must be cautious during the
preparation and administration of these medications to help protect their patients from avoidable
errors. Continuous education is suggested to provide RNs with updated information regarding
patient well-being and safe medication handling, including best practices for preparing
medications (Luokkamäki et al., 2020). Additionally, it is recommended that unit leaders observe
RNs during their MA practices, as this is the best way to identify opportunities for improvement
based on the actual habits of RNs during medication handling (Mulac et al., 2021). Ultimately,
based on the available evidence and survey responses from the microsystem’s nursing staff, it
was believed that the intervention that would be most impactful on the MA practices of the RNs
was the implementation of visual reminders to access the eMAR during the preparation of
injectable medications.
Rationale
The model that will guide this quality improvement project is the Plan-Do-Study-Act
(PDSA) cycle. As described by the Agency for Healthcare Research and Quality, the PDSA
model helps to guide QI projects by organizing the planning process, creating specific steps to
guide change, evaluating outcomes, making improvements based on the outcomes, and then
attempting to create change again (Agency for Healthcare Research and Quality, 2020).
According to the text by Nelson et al., the focus of the PDSA cycle is to experiment change ideas
and collect data to determine if an intervention created a meaningful improvement (Nelson et al.,
2007). Furthermore, this model is beneficial because it can be completed quickly and does not
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require extensive resources, including money (Nelson et al., 2007). Quality improvement is a
process that requires careful planning and patience. Given the benefits of utilizing the PDSA
cycle and the significance of the identified problem, this model for improvement is a great
framework for this QI project.
Plan
During the planning phase of this QI project, 20 observations were made of the
microsystem’s RNs during the preparation of injectable medications. Also, the preimplementation survey was distributed during this phase, as the responses helped in planning the
intervention. The responses and observations served as the pre-implementation data and helped
to describe the state of the microsystem prior to the intervention. The intervention was identified
and carefully planned during this phase of the PDSA cycle. Also, during this phase, the Project
Leader (PL) was assigned as being the individual responsible for leading the intervention. A
timeline was created for when the intervention will be implemented and when the data analysis
process will begin. Additionally, this phase included the process of creating the education and
visual reminders that were part of the formal intervention process.
Do
This step includes the process of carrying out the intervention, as organized during the
previous phase. The team responsible for directing the project, as identified during the Plan step,
provided the RNs with education regarding the importance of safe medication preparation
practices and then observed those who consented to participate in the project during medication
preparation. While these observations were made, documenting the findings was an essential part
of this phase, as they would then be analyzed in the subsequent phase. Furthermore, the QI team
made note of strengths and weaknesses of the intervention which will help guide future PDSA
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cycles for this project. During the final week of the intervention, the participants were also asked
to complete a post-implementation survey which assessed their knowledge regarding safe
medication practices and the usefulness of the visual reminders.
Study
Following the data collection process, the QI team analyzed the results and reflected on
the overall success of the intervention. During this step, the QI team compared the actual results
with the project’s Specific Aim. Data analysis was planned to be performed using descriptive and
inferential statistics as described throughout the subsequent sections of this project. Once this
was completed, the team then debriefed the members of the microsystem regarding the results of
the intervention and worked to identify future potential changes that will help advance the
improvement process. This phase also included the process of summarizing the lessons learned
by both the QI team and the RNs that participated in the project.
Act
The final step of this cycle included the process of determining if the intervention should
be modified or abandoned. Given the understanding that QI is a continuous process, it was
expected that this project will require additional PDSA cycles. Based on the lessons learned from
this cycle, the QI team will modify the current intervention (or create a new one) to better meet
the project’s Specific Aim. See Conclusions for information regarding the ideal next steps of this
project.
Specific Aims
As described throughout the Problem Description, 13 (65%) of the 20 witnessed
preparations of injectable medications were observed to have been completed at the counter
located at the nurse servers. Because this location is not equipped with the technology required to
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access the order details within the eMAR, these medications were prepared while disregarding
the rights of MA, including the right dose. This is a dangerous practice that places patients at risk
for harm due to the increased likelihood for the RN to make a medication error. Given these
potential consequences to patient safety, the specific aim of this QI project was to decrease the
percentage of RNs that prepare injectable medications at the nurse server counter from 65% to
50% by July 29, 2022. Interventions to achieve the aim of this project included providing
education on the importance of adhering to the rights of MA and creating visual reminders at the
nursing servers to redirect the RNs to access the eMAR while they prepared injectable
medications. The implementation of these visual cues was thought to accomplish the aim of this
project given the review of the evidence as analyzed within the Available Knowledge.
Furthermore, this QI intervention was meant to meet the global aims of this project which
were to promote the usage of the electronic medication administration record and reduce the risk
for medication errors. This is critical as it directly relates to patient safety which is a priority for
nursing practice. It was expected that the microsystem’s RNs would be observed to utilize the
eMAR more frequently given the implementation of this intervention; however, future PDSA
cycles would be needed to accomplish the specific aim.
Methods

Context
Medication errors have the potential to occur during any of the steps involved in
medication administration. However, the medication preparation process is known to carry
significant risks as this is the point in the process where the dose must be drawn up correctly
based on the prescribed amount that is reported in the patient’s electronic medication
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administration record. Because of the risk potential during this process, the proposed intervention
for this quality improvement project took place during the medication preparation phase.
To help support the implementation of this QI project, a thorough cost/benefit analysis
was conducted which considered the costs associated with the intervention in comparison with
the known costs of medication errors. According to the World Health Organization, the global
cost of reported errors, including a patient receiving the incorrect dose of their medication, is
estimated to be $42 billion (World Health Organization, 2017). From a national perspective, the
United States Food and Drug Administration reports that they receive more than 100,000
medication error-related claims each year (United States Food and Drug Administration, 2019).
Furthermore, the Academy of Managed Care Pharmacy states that the added costs to care for
injuries associated with medication errors originating in hospitals is around $3.5 billion each year
(Academy of Managed Care Pharmacy, 2019). Given that MAEs are regarded as preventable
events, any intervention to enhance the safety during the medication administration process
would contribute towards lowering these known costs.
Because of the survey responses by the microsystem’s RNs (see Problem Description), it
was decided that creating visual reminders and distributing them throughout the unit was the
most practical initial intervention to meet this project’s specific aim. Ideally, this intervention
would have included the addition of a computer at the nurse server counter, so that the RNs
could access the eMAR at their preferred preparation spot. However, the addition of a computer
is associated with a cost that exceeds the budget of this QI project. Given this consideration, the
decision was made to pursue the idea of utilizing visual cues about the importance of viewing the
order details during the preparation of injectable medications due to the minimal cost
requirements and ability to be implemented by July 29, 2022.
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Intervention
The first part of this multifaceted intervention began with sharing the survey results with
the nursing staff of the microsystem as this heightened their awareness to the local problem and
provided more context to their responses. The results were displayed in the form of a PowerPoint
presentation, so that visuals could complement the data. This presentation also included a brief
educational portion regarding the importance of accessing the eMAR during the preparation of
injectable medications, given the increased risk for harm to patients if administered incorrectly.
This presentation was emailed to 100% (N = 16) of the RNs responsible for medication
administration and was also shared with the microsystem’s three nursing managers. Also, printed
copies were provided for the unit to view during moments of downtime, should they not access
the electronic copy that was sent via email.
Once the awareness portion of the intervention was completed, the implementation
process continued with creating visual displays to serve as reminders to view the eMAR while
actively drawing up the medications. Since the counter at the nursing server was reported to be
the preferred location for medication preparation, the graphic was on display here to remind
most, if not all, of the RNs of this intervention. Additionally, the visual was placed on the door of
the medication room, which is where medications are securely stored, so that the RNs could see
it as they enter and exit the room. Because disruptions can alter the RN’s focus during MA, the
visual was intended to remind, not distract. To ensure this, the dimensions did not exceed 8.5 x
11 inches. The visual contained a red octagon, resembling a stop sign, containing the phrase,
STOP; Don’t forget to access the eMAR during med prep! (See Appendix A). This was meant to
increase the RNs’ accountability to the intervention since they were being reminded during the
active process of preparing medications.
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The team responsible for the implementation of this project was comprised of the Clinical
Nurse Leader (CNL) student who served as the Project Leader and a CNL who works within the
organization, but on a larger medical-surgical microsystem. The CNL acted as a mentor to the
PL during the entire QI process. The microsystem’s RNs were also key stakeholders as they were
responsible for the preparation and administration of medications. Their involvement allowed for
the implementation of this QI project; therefore, it was essential to consider their feedback when
designing this project.
Study of the Intervention
The intervention was studied by comparing the pre- and post-implementation observation
data. Prior to the intervention, 20 observations were made in which RNs prepared injectable
medications. 13 (65%) of the observations were of nurses preparing medications without
reference to the eMAR at the supply counter. During the post-implementation period, the PL
planned to observe 20 additional medication preparations and record the frequency at which RNs
prepare medications at the counter. The collected data was then used in determining the impact
of the intervention because it measured the frequency of RNs that did not consult with the order
details during this process. Observing the same amount of medication preparations would help to
keep the data consistent given the identical sample sizes. In addition to the post-implementation
observations, the RNs were surveyed again to assess the safety of their MA practices and to
record the frequency at which they access the eMAR during this process. The results from these
datasets were presented in terms of percentages and frequencies (see Results). Additionally, the
combined results were planned to be analyzed using inferential statistics, in the form of a paired
t-test, to evaluate the impact that the intervention had on the RNs’ MA practices.
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Measures
The rationale for gathering data through observations was made because of previously
identified discrepancies between reported and actual adherence to policies, including BCMA.
The microsystem’s staff described their total adherence to the double-checks put in place by
verifying the Rights of Medication Administration. However, it was observed that this is not the
case, hence the reasoning behind this QI initiative. By collecting data through observing this
process and then surveying the staff, the PL could better understand the practices in place and the
barriers to safely preparing medications for patients, including lack of access to the eMAR. For
the purpose of this QI project, observations were considered complete and successful when the
PL could visualize the RN from the point of leaving the medication room to the moment when
the RN begins to prepare an injectable medication without accessing the eMAR’s order details.
The conclusion of the observation process could be done at any location where the medication
was drawn up, including the RN station, medication room, and the counter at the nurse server
and supply cabinets.
Since this intervention began with an educational component, the ability for the staff to
comprehend the information presented by the PL was also considered when evaluating the
outcomes. To ensure that the staff understood the importance of incorporating the eMAR into
their MA practices, opportunities for on-going learning in the form of the printed presentation on
display in the staff conference room and availability for the PL to be present on the unit to field
for questions and feedback from the staff was provided throughout the duration of the process.
This was particularly helpful as it incorporated various learning styles, like visual and auditory.
Ultimately, the success of this intervention was determined by comparing the results with
the specific aim of this project. It was anticipated that achieving the specific aim would require
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several cycles of the Plan-Do-Study-Act model; therefore, this project would not be considered
an overall failure if the aim was not achieved after one cycle of data collection. Additionally,
when making post-implementation observations, the PL planned to observe these processes
during the Monday-Friday, 7:00am-7:00pm shifts, as this is when the pre-implementation data
were collected and would contribute towards data accuracy. Since this project was conducted
within a microsystem that the PL did not hold a formal position in, it was critical to acknowledge
the possibility of the staff having competing priorities which may interfere with their
participation during the intervention phase. If this were the case, the PL would re-evaluate the
current state of the microsystem and make the necessary adjustments to the plan of this project.
To determine the validity of collected data through observations, a systematic review by
Ferguson et al. (2018), exploring best practices for conducting observational data, was analyzed.
After searching various databases, the researchers included 12 studies that satisfied their search
criteria. From these studies, the authors proposed implications to practice when collecting
observational data, including the ideal number of observations. Based on their review, the
researchers believe that there is no definitive number of observations needed to ensure total
validity and reliability of data. However, as the number of observations increase, so do both
indicators (Ferguson et al., 2018). The studies included for review felt that upwards of ten
observations were sufficient to obtain dependable data (Ferguson et al., 2018). Given these
findings, the decision to include 20 observations for data collection is consistent with the
psychometric considerations as outlined throughout the review.
Analysis
The results from both the pre- and post-implementation observation data were
summarized with quantitative analysis. Descriptive analysis illustrates the results by indicating
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the percentage and frequency of RNs who prepare injectable medications with and without
accessing the eMAR. Inferential statistics would also be used during the analysis, as it aids in
understanding the impact that the intervention had on the microsystem’s RNs. A paired t-test
would be conducted to compare the pre- and post-implementation observations and survey
responses to determine if the visual reminders were responsible for accomplishing the specific
aim of this project.
During the analysis process, it was essential to understand the variation within both
datasets. Of the variables present, time had a significant impact on both the data collection and
evaluation steps. With respect to the timeline of this project, there was approximately two
months available for the intervention to be implemented and the post-implementation data to be
collected. Ideally, the 20 observations would have been collected within two-to-three weeks.
However, had the 20 observations not been made, the time frame for data collection would have
to be extended which would allow for less time to evaluate the data; this was the case for this
project. Conversely, the pre-implementation data were gathered over the course of two months.
This allowed for the PL to successfully observe the preparation process 20 times. The time
allotted for this project serves as another example of time being a limiting factor for the success
of the intervention. The quality improvement process is known to be a continuous process of
planning, intervening, evaluating, and adjusting as needed. Only one cycle of the PDSA model
was completed during this project, which limited the change potential. Finally, observations were
planned to have been made during Monday-Friday from 7:00am-7:00pm, meaning that
information about the RNs who work during the opposite shift (7:00pm-7:00am) would not be
included in the data. This limited the ability to prove the impact of the intervention on the
microsystem since only a fraction of the professionals involved would be observed.
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Another opportunity for variation was the potential for the response rates to fluctuate
between the pre- and post-implementation phases. The pre-implementation survey had a 56.3%
(n = 9) response rate. Ideally, more of the RNs would have participated in the postimplementation survey; however, this was addressed when analyzing the results of this project.
Ethical Considerations
As stated by the American Nurses Association, “life and death decisions are a part of
nursing, and ethics are therefore fundamental to the integrity of the nursing profession”
(American Nurses Association, n.d., Ethics and Human Rights section). The aim of this QI
project was to enhance RNs’ likelihood of double-check the dosing with the prescription
information in the eMAR. This outcome allows for patients to safely receive medications while
being cared for in the acute care setting, a concept that relates to nurses providing care that is
consistent with the profession’s ethical obligations. While patients were not the primary
population of interest throughout this project, the intervention was aimed at ensuring RNs safely
prepare the medications that are then administered to patients, meaning they would also benefit
from the success of this project. All patient identifiers, including name, date of birth, medical
record number, and room assignment during admission, were excluded from this project to
respect patient confidentiality.
With respect to the ethical considerations of the professionals that were observed, it is
important to note that the PL did not inform the RNs that they were being observed during this
process. The rationale behind this was to avoid observer bias and to gather data that reflects the
actual practices of the staff. Information about the observed RNs, including their name, was not
recorded to promote confidentiality. Once these observations were completed, the RNs were then
made aware of the local problem. The survey that was distributed to the staff was voluntarily

ENHANCING THE SAFETY OF MEDICATION PREPARATION

24

completed, as there were no repercussions should someone choose not to complete it. Also, the
responses were kept anonymous to promote honest feedback. One of the survey items allowed
for the RNs to provide a free text response describing their personal barriers to consulting with
the eMAR during medication preparation. These responses were then reviewed and taken into
consideration during the intervention planning phase. Incorporating their input allowed for the
PL to promote staff engagement to both the problem and the importance of the intervention by
allowing them to take part in the planning process. Prior to implementing the intervention, the
RNs were asked to complete an informed consent document that allowed for them to agree or
disagree to participate in the next step of the project (See Appendix B).
Approval for this project was given by the microsystem’s leadership team, including the
Unit Managers and Unit Educator. Additionally, the University of New Hampshire’s Nursing
Department Quality Review Committee approved this project as meeting the criteria for a QI
project, which is exempt from Institutional Review Board review.
Results
Results
The intervention phase of this project began on June 20, 2022, with the microsystem’s
RNs completing an informed consent to participate. This process was expected to begin prior to
this date; however, coordinating with the staff to begin the enrollment period took longer than
anticipated due to planned vacation times and delayed responses. The informed consent process
concluded on June 27, 2022, with six (N = 6) RNs enrolled to participate. This is a modified end
date, as it was planned to be completed by June 24. However, by this date, five RNs had agreed
to participate which was less than the ideal enrollment of six-to-eight participants. Because of
this, the informed consent process was extended to accommodate for further enrollment. Once
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six RNs were enrolled to participate, the informed consent process ended and the education
meetings began on June 27. During this time, the Project Leader met with the enrolled RNs and
reviewed the pre-implementation survey results to heighten their awareness of the local problem.
Also, during this education session, the PL reviewed important concepts for safe medication
administration, like the Seven Rights of Medication Administration and how to appropriately
utilize the BCMA system. The education concluded with the review of policies related to safe
MA practices as published by the organization. The educational sessions were planned to end on
July 8, 2022; however, to better accommodate the RNs’ schedules, they continued until July 11.
These meetings took place in the microsystem’s conference room and lasted around 10 minutes
in duration. The implementation of the visual reminders began on July 5, 2022. On this date, the
PL placed three visuals throughout the microsystem (one in the medication room where the
medications are dispensed and two at the nurse server station where the medication supplies are
stored). Once these visuals were put on display, the observations began with the RNs. To
conform with the end date of this PDSA cycle, the observations ended on July 15, 2022. It was
planned that the PL would observe 20 preparations of medications as completed by the RNs who
consented to participate in this QI project. However, by July 15, the PL was only able to observe
10 preparations given the limited number of injectable medications ordered for the
microsystem’s patients during this timeframe. The final portion of the intervention began on July
11 with the distribution of the post-implementation survey to the participants. The survey was
activated and sent via email on July 11 and expired on July 15, 2022, at 9:00pm, marking the
conclusion of the intervention. Figure 1 illustrates the overall timeline of the intervention.
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Figure 1
Intervention Timeline

Once the intervention was completed, the results were analyzed. To best track the various
phases of the intervention, a Microsoft Excel spreadsheet was created that tracked which RNs
have enrolled, the date of their informed consent, the date of their education session, the date(s)
that they were observed, and the date they were sent the post-implementation survey. Each
participant was assigned a number that was used to track their involvement in the project without
recording their name. The observational data were also tracked on this spreadsheet, making note
of the location where the medications were prepared. The data collection process was planned to
be considered complete once a total of 20 observations were collected, but the process was
terminated at 10 observations given the deadline for this PDSA cycle. Of the 10 preparations of
injectable medications that were witnessed by the PL, one (10%) was completed at the nurse
server counter, one (10%) was completed at the computers at the nurses’ station, and eight (80%)
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of the instances included the RN gathering the supplies at the nurse server station and bringing
them into the patient’s room. Figure 2 provides a visual of these results.
Figure 2
Location of Injectable Medication Preparation

10%
10%

80%

Nurse server counter

Nurses' station computers

Patient's room

Note. There were a total of 10 observations (N = 10).
Though the observational data were the primary datapoints used to determine the success
of this project, the RNs were also asked to complete a post-implementation survey which
assessed their understanding of safe MA practices following the intervention. All six of the
participants were emailed the survey and asked to complete it prior to the last day of the
intervention (July 15, 2022). Once it was closed, there was an 83.3% (N = 5) response rate. The
survey items, presented on a five-point Likert scale, assessed the RNs’ knowledge of safe
medication practices and allowed for them to provide feedback regarding the effectiveness of the
intervention. When asked if their knowledge of safe MA practices had improved following the
education portion of the intervention, the responses were as follows: Strongly agree (n = 2
[40%]), Agree (n = 2 [40%]), and Neither agree nor disagree (n = 1 [20%]). Additionally, the
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survey asked the participants to respond if the use of the visual reminders encouraged them to
access the eMAR while preparing medications, the responses were as follows: Strongly agree (n
= 1 [20%]) and Agree (n = 4 [80%]). The survey continued by asking the RNs if they believe
they safely prepare injectable medications for their patients in which three RNs (60%) responded
Always and two (40%) responded Often. Furthermore, the RNs were asked if they refer to the
eMAR while they actively prepare injectable medications, the responses were as follows: Often
(n = 4 [80%]) and Sometimes (n = 1 [20%]). Finally, given the potential for the presence of
observer bias to interfere with the results, the survey asked the participants if the presence of the
observer made them more likely to access the eMAR during the preparation process. The
responses to this survey item are as follows: Strongly agree (n = 2 [40%]) and Agree (n = 3
[60%]). Table 1 presents these responses as a mean, standard deviation, and range. The fivepoint Likert scale items were assigned a numerical value (1-5) for statistical analysis purposes
with Strongly disagree and Never (1) to Strongly agree and Always (5), respectively.
Table 1
Descriptive Statistical Analysis of Post-Implementation Survey Responses
Survey Item
I believe that the education portion of this project
enhanced my knowledge of safe medication practices

M

SD

R

4.2

0.8

1-5

The visual reminders encouraged me to access the
eMAR while I prepare injectable medications

4.2

0.4

1-5

I safely prepare injectable medications to my patients

4.6

0.5

1-5

I refer to the eMAR while I am actively preparing
injectable medications

3.8

0.4

1-5

0.5

1-5

When I am being observed, I am more likely to access
4.4
the eMAR while preparing injectable medications
Note. Range (R), electronic medication administration record (eMAR).
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The intervention phase of this QI project was planned to begin in the beginning of June
and be completed by the second week of July. However, several variables interfered with this
plan, resulting in a delay in beginning the implementation of the intervention. A major obstacle
to this project was that the microsystem’s leadership team had taken days off throughout the
weeks. This negatively impacted the timeliness of this project because it resulted in delayed
responses to emails and questions by the PL regarding the logistics of the project. Aside from
days off, another barrier to the implementation of this project was that the RNs did not complete
the informed consent within the week allotted. This led to the extension of the enrollment
process which required the next steps of the intervention to be delayed, as well. Furthermore, the
level of engagement from both the unit leaders and RNs varied based on the microsystem’s
current priorities. This microsystem is experiencing staff shortages, as most healthcare settings
are, which caused the RNs to feel less inclined to participate in this project given the
misconception that their involvement would increase their workload. Given this consideration,
the PL carefully explained the time commitment to this project to the staff. After confirming that
there were no extra requirements to their workload, enrollment began to increase. The data
collection process was forced to end prior to collecting 20 observations. After being on-site at the
microsystem for several days, the PL was only able to observe 10 instances of injectable
medication preparations. Upon further investigation, it was realized that the majority of the
patients that the enrolled RNs were caring for were being transitioned to oral medications since
they were being discharged during that shift. Additionally, of the six enrolled RNs, four were
serving as charge nurses. While serving in this role, they were not given a patient assignment,
which meant they were not responsible for medicating patients. This was the primary reason why
the PL was unable to observe 20 total preparations.
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While there were several barriers to implementing this intervention, the planning process
was done diligently to expect some of these obstacles, so it was simple to restructure the timeline
for implementation. However, the PL did not anticipate for the lack of opportunities to observe
RNs during their medication preparations, so this is considered to be a limitation of the project.
Because of the limited opportunities to observe the participants, the results were unable to be
analyzed using inferential statistics, as planned, which is considered to be another limitation of
this project. Furthermore, given the difficulties to collect enough observations, the PL had to be
on-site more than planned, for a total of 36 hours, which is regarded as an unexpected cost of this
project.
During the planning process, it was believed that there would be a degree of missing data
since it was anticipated that the observations would be collected during the Monday-Friday
7:00am-7:00pm timeframe. However, to allow for more participants, the PL allowed for RNs
who work the opposite shift to be eligible, resulting in the education sessions and observations to
be completed during the 7:00pm-7:00am shift, as well. Though the hours were extended during
the Monday-Friday week, the PL was not on-site during the weekends; therefore, data reflecting
the MA practices during this time was not captured. Finally, while observing the nurses, the PL
noticed other RNs that were still preparing medications at the nurse server station. However,
these nurses did not provide consent to be included in the data collection process, so these
findings were excluded from the results. Because of these considerations, the results do not
adequately reflect the success of this QI project.
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Discussion
Summary
The findings of this project suggest that the percentage of RNs that prepare injectable
medications at the nurse server counter went from 65% to 10%. While this may seem like the
specific aim of this project was met, the sample size of observations varied between the pre- and
post-implementation phases. Given this discrepancy, it cannot be concluded that a true
improvement was made. Regardless of the number of observations collected, the PL terminated
the intervention on July 15, 2022, to accommodate for the predetermined deadline of this QI
initiative, as set during the Plan phase. The overall key findings include an increased awareness
of safe medication practices, attention to workflow considerations, and the benefits of visual
reminders.
Increased Awareness of Safe Medication Practices
This project excelled at raising awareness of safe medication practices throughout the
microsystem. Because of the importance of patient safety and implementing best practices
regarding safe nursing care, the project’s global aim was set to promote the usage of the
electronic medication administration record to reduce the risk for MAEs during medication
preparation and administration. By providing the RNs with education around this and
implementing the visual reminders, it appears that the global aim was met, which is regarded as a
strength of this improvement project. This was primarily made evident after analyzing the postimplementation survey results.
Workflow Considerations
While reviewing the survey responses, the RNs reported their interest in having a
computer placed at more convenient locations throughout the microsystem, including the

ENHANCING THE SAFETY OF MEDICATION PREPARATION

32

medication room and the nurse server station. Initially, it was believed that referencing the
eMAR while actively preparing injectable medications was not being done because of a potential
knowledge deficit. However, the results from this intervention suggest that a lack of knowledge
is not necessarily what was deterring the RNs from doing this during MA. Based on the survey
results, it appears that the microsystem’s workflow does not support the use of the eMAR during
this phase of medication administration. The RNs identifying a need for more efficient access to
technology throughout the unit is also regarded as a strength of this project, since this
information is useful when planning a future PDSA cycle to improve this process.
Benefits of Visual Reminders
While observing the participants, it was noticed that the majority of the preparations were
being done at the patient’s bedside, rather than at the nurse server counter. Since this location
provides the RN access to the order details, this is another key finding from this project. Not only
does preparing medications at the bedside allow for the RN to adhere to the policies regarding
BCMA and the Seven Rights of Medication Administration, but it also allows for the patient to
become more involved in their care. Additionally, the survey responses from the participants
identified that they also found the visual reminders to be an effective method of reminding them
to access the eMAR during this process.
Interpretation
Since 20 observations were unable to be collected, the results cannot be used to
determine an association between the findings and the intervention. While the results show a
decrease in the percentage of nurses who prepare injectable medications at the nurse server
station, it appears that the concept of observer bias is what has led to these findings. The survey
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responses (see Results) support that observer bias was present during the observations, so the
results likely do not reflect the actual practices of the RNs.
The results of this quality improvement project are similar to the findings from other
publications that studied the process of medication preparation and the use of technology to
enhance the safety of MA. According to the systematic review by Smeulers et al. (2018), visual
reminders helped to support nurses during their medication administration practices. Specifically,
the implementation of these visual reminders provided nurses with additional support to ensure
that they are adhering to the Seven Rights of Medication Administration (Smeulers et al., 2018).
These findings relate to this QI project given that the visual reminders seem to have enhanced the
process of referring to the eMAR while actively preparing medications.
As mentioned, the idea of observer bias played a role in the results of this project. Other
publications have addressed this concept and how it may skew the results when gathering data
via observations. The observational study, organized by Mulac et al. (2021), discussed this idea
in detail given the results from their project when studying how nurses use the BCMA system
when providing medications to patients. As described in this study, the researchers agreed that
the presence of an observer applied a level of pressure on the nurse to use the technology
correctly and modified their behavior to reflect what they thought was expected of them during
the MA process (Mulac et al., 2021). This may have been a subconscious behavior change, but
still created a discrepancy between the observed process and the actual process, that is, when an
observer is not present. These findings relate to this QI project because the Project Leader found
that the nurses were more likely to gather the medication supplies and then take them into the
patient’s room to prepare since there is access to the eMAR at this location. However, when
reviewing the responses from the pre-implementation survey, the nurses unanimously agreed that

ENHANCING THE SAFETY OF MEDICATION PREPARATION

34

their preferred location to prepare medications was at the nursing server station. To respect the
privacy of the patients, the PL did not enter the patient’s room once the nurse went in, so the
remainder of the preparation process was not observed to completion. However, while on the
unit, the PL noticed that other nurses who did not consent to participate in this project were still
preparing medications at the nurse server counter. Since these nurses did not consent to
participate, this data was not included in the data collection process. Given these findings, it is
possible that the presence of the observer (PL) encouraged the nurses to do what they felt was
expected of them during this process and prepare the medications at the patient’s bedside.
Throughout the planning phase of this project, it was believed that there would be an
improvement from the pre-implementation observations. This was thought to be the case given
the idea of observer bias and the pressure that the nurses may have felt while being observed.
Though an improvement was expected, it was not anticipated that there would be a 50% change.
Based on the results, it appears that the percentage of nurses who prepare injectable medications
at the nurse server station has decreased from 65% to 10%. While this is ideal, it is not
representative of the actual practices in place throughout the microsystem. This is said due to the
observed behaviors of the nurses who did not consent to participate in this intervention. A likely
reason for the discrepancy between observed and anticipated outcomes is the influence of the
observer during the process.
Despite the possibility that observer bias interfered with the results, this project had a
positive impact on the nursing staff and patients, as it promoted the adherence to the Seven
Rights of Medication Administration, a concept aimed at protecting patients from harm when
receiving medications. Additionally, this positively impacted the nursing staff since it
encouraged them to utilize the BCMA system responsibly and verify the medication orders while
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preparing the medications for their patients. In doing this, the nurse is more likely to catch
mistakes before they reach the patient. Furthermore, this QI project positively impacted the
overall microsystem given the presence of the visual reminders throughout the unit. While only a
fraction of the nurses consented to participate, the other nurses responsible for patient care were
still exposed to these reminders and may have found themselves gathering their medication
supplies and preparing them at a location equipped with the eMAR. Guiding an intervention that
enhances the process of medication administration is critical given the importance of patient
safety; therefore, this project positively impacted the overall microsystem and healthcare system.
Additionally, this initiative has the opportunity to be sustained beyond this Plan-Do-Study-Act
cycle, should another nurse decide to continue with this project. Because of this potential, there
is the possibility for furthered improvements and the likelihood to the meet the specific aim,
which touches upon the opportunity costs of this project.
Limitations
There are several limitations to the findings of this quality improvement project. The
majority of these limitations are related to the predetermined deadline for this project. Given the
deadline of July 29, 2022, only one PDSA cycle was able to be completed. The QI process is
known to be a continuous process that requires multiple PDSA cycles to achieve optimal
outcomes. Because of this, the one completed PDSA cycle was not significant enough to create
meaningful change within this microsystem. Since there was limited time to complete the
intervention portion of this QI project, the PL was unable to extend the enrollment phase any
longer, which meant only six RNs were able to participate. The limited number of participants
meant that there would be minimal opportunities to observe the process of preparing injectable
medications. The findings from the 10 instances that were observed were unable to be used to
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determine the success of the intervention since the pre-implementation data were based on 20
observations. Additionally, only five out of the six participants completed the postimplementation survey, so the responses do not reflect the beliefs of all of the RNs who
participated.
Other limitations were due to the proposed data collection plan for this project. While
observational data best reflect the actual practices of RNs during MA, the PL was the only
individual who was observing these instances. Since the PL could not be present at all times, the
results represent a fraction of the actual instances of medication preparation. Furthermore, it was
determined that the presence of the observer during this process encouraged the RNs to perform
how they thought they were expected to, a concept known as observer bias. Due to the
limitations of this QI project, it cannot be concluded that the implementation of visual reminders
to access the eMAR during the preparation of injectable medications was effective enough to
guide change within this microsystem.
In an attempt to limit observer bias, the PL sat at the nurses’ station during the times
when the participants were going to prepare injectable medications for their patients. This
location was chosen given its proximity to the nurse server counter. It was believed that by
sitting here, the PL would be able to observe from a distance, so that the RNs would not feel like
they were being watched. However, the participants would typically dispense the medications
and then approach the PL indicating that they were ready to be observed. While this was helpful
for the PL to know when the observations were going to occur, it confirmed the presence of
observer bias. Since there were no other locations for the PL to sit and have a visual of the nurse
server counter, this location remained as the primary vantage point throughout the duration of the
intervention which interfered with the data collection process.
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Finally, the generalizability of these results is limited to microsystems with similar
constraints regarding access to the eMAR at areas where medications are prepared.
Microsystems with adequate access to the technology at their medication preparation stations are
less likely to experience the same problem as the microsystem that was studied throughout this
project. Therefore, it is believed that only units with similar barriers to accessing the eMAR will
find value in reviewing this project in attempts to improve their microsystem. However, these
findings support the importance of end user considerations when planning and organizing a
microsystem. If the staff are expected to adhere to policies, the environment must support the
workflow. These considerations are relevant to all microsystems.
Conclusions
In studying the process of preparing injectable medications, individuals are able to learn
more about their own personal practices related to medication administration. Additionally, this
brings heightened awareness to the importance of patient safety as it directly relates to the Seven
Rights of Medication Administration. This project identified that inadequate access to the eMAR
was the primary reason as to why the RNs were not referring to the medication orders while
preparing injectable medications for their patients. Discovering this allows for additional ideas
when planning future cycles for this QI project.
This project is particularly sustainable given that there were no economic costs associated
with planning or carrying out the intervention. Moreover, since patient safety is a major concern
for the current healthcare system, the need to study how RNs prepare and administer medications
for their patients will always be in demand, indicating that the topic will continue to be relevant.
However, the PL found this project to be somewhat unsustainable at times due to the need to be
physically present on the unit to carry out the phases of the intervention. In order to make this
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project more sustainable for future cycles, it is recommended that someone who is more familiar
with the microsystem staff and who works on the unit already be the individual to lead the efforts
for this project. This will allow for the leader to be on-site on a more regular basis which will
allow for better observations.
While reviewing the results with the CNL who served as the mentor to the PL throughout
this project, it was mentioned that these results could be presented to other nursing leaders and
managers who are involved in the planning of new patient units that are currently under
construction at the hospital that this microsystem is located in. The participants’ emphasis on
wanting more efficient access to the eMAR at locations where they prepare medications may be
able to contribute towards how the new units are designed, as well as inspire modifications to
existing units. This may include ensuring that the patient’s rooms are equipped with adequate
space for medication preparation or providing computers at the nurse server counter. The
potential to contribute towards the planning process for the future patient units highlights the
impacts that this QI project has on the overall process of enhancing patient safety when
preparing medications.
The results of this project indicate that this process needs to be furthered examined to
best support nurses during medication preparation and to ensure that patients are remaining free
from harm when in the hospital environment. The survey responses from the participants brought
awareness as to why they were not observed to have accessed the eMAR during the pre- and
post-implementation observations. Given the impact that the visual reminders had on accessing
the eMAR, as identified by the post-implementation survey responses, it is suggested that these
visuals remain on display to serve as continuous reminders. Since the RNs agreed that they
would be more likely to refer to the medication orders if there was better access to the
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technology throughout the unit, it is recommended that at least one computer be placed at the
nurse server counter. If this can be done, then it is recommended that future PDSA cycles study
the actual use of the newly placed computer(s) to determine if this was the true barrier.
The results from this PDSA cycle suggest that future cycles must be completed to further
improve the current process of preparing injectable medications. Recommended next steps
include identifying at least one new PL, since this PL will no longer be working within this
microsystem. This PL should have an understanding of the overall quality improvement process
and be equipped with the basic skills necessary to lead a process improvement project.
Additionally, a conversation should be engaged in with the microsystem’s management staff to
explore the feasibility of relocating a computer from the nursing stations to the nurse server
counter. If this can be accomplished, this should be the basis of the next PDSA cycle. It would be
beneficial for the PL to study the use of the technology by observing participants during their
medication preparation practices and by assessing their satisfaction with the placement of the
computer. In furthering this project, a more valid attainment of the specific aim is likely to occur
which will contribute towards enhancing the safety checks in place to protect patients from harm.
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